HLNE Stock Recent News

Hamilton Lane (HLNE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

CONSHOHOCKEN, Pa. , March 25, 2025 /PRNewswire/ -- Hamilton Lane (Nasdaq: HLNE), a leading global private markets investment management firm, announced an investment in a portfolio of four multifamily assets in lower Manhattan.

Hamilton Lane Private Infrastructure Fund ("HLPIF") allows retail investors access to infrastructure assets previously accessible only to Hamilton Lane's institutional clients Intention to offer investors access to HLPIF in a first-of-its-kind tokenized format through Republic's digital platform CONSHOHOCKEN, Pa. and NEW YORK , March 19, 2025  /PRNewswire/ -- Hamilton Lane (Nasdaq: HLNE), one of the world's largest private markets investment firms, today announced the launch of HLPIF on the global investment platform Republic*.

Research findings note some areas of concern in private markets in the short-term, with positive tailwinds across long-term fundamentals Report also highlights strong runway for growth within evergreen CONSHOHOCKEN, Pa. , March 12, 2025 /PRNewswire/ -- Hamilton Lane (Nasdaq: HLNE), a leading global private markets investment management firm, published its 2025 Market Overview today.

Fund leverages firm's 24+ years of experience in the secondary market and extensive scale to capitalize on what the firm believes to be attractive long-term growth trends CONSHOHOCKEN, Pa. , March 3, 2025 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (Nasdaq: HLNE) today announced the launch of the Hamilton Lane Private Secondary Fund ("HLPSF" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Company Act of 1940 ("40 Act"), available to U.S. accredited investor clients, including sufficiently qualified high-net-worth investors and their wealth advisors.

Erik Hirsch, Hamilton Lane Co-CEO, joins 'Closing Bell Overtime' to talk why the IPO boom isn't materializing.

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma's Board of Directors has unanimously recomm.

Q3 results showed revenue up 34% year over year, coupled with strong overall profitability, both benefiting from higher incentive fees. Underlying growth in assets under management/advisement was muted, up just 6% year over year. While growth is expected to slowdown in the coming quarters, shares remain richly valued at 34.6 times earnings.

CONSHOHOCKEN, Pa. , Feb. 10, 2025 /PRNewswire/ -- Private markets asset management firm Hamilton Lane Incorporated (Nasdaq: HLNE) ("Hamilton Lane") today announced the pricing of an underwritten public offering by Hamilton Lane and a selling stockholder of 1,572,536 shares of Class A common stock, in the aggregate, for gross proceeds of approximately $252 million.

Erik Hirsch, Hamilton Lane Co-CEO, joins 'Fast Money' to talk the impact of tariffs on the market.